Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metviron GP 2 Tablet

Prescription Icon
Prescription Required

Marketer

Nvron Life Science Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Metviron GP 2 Tablet

Glycemia Duo tablets are classified as antidiabetic medications, a dual-drug formulation for managing type 2 diabetes in adults. These tablets help regulate blood glucose levels. Glycemia Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are vital to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women must consult their physician before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Metviron GP 2 Tablet

Managing type 2 diabetes

Major Benefits of Metviron GP 2 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metviron GP 2 Tablet whole; avoid chewing, crushing, or breaking it. It should be administered with food.

Common Side effects of Metviron GP 2 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metviron GP 2 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metviron GP 2 Tablets should be taken with a meal.

How Metviron GP 2 Tablet works:

Metviron GP 2 Tablet combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Metviron GP 2 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metviron GP 2 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Metviron GP 2 Tablet are incompatible; the medication poses a potential toxicity risk to infants.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Metviron GP 2 Tablets cautiously, potentially requiring dosage modification under medical supervision. Metviron GP 2 Tablets are contraindicated in individuals with severely compromised kidney function. Regular assessment of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metviron GP 2 Tablets cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is typically prescribed for those with mild to moderate liver disease; it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metviron GP 2 Tablet :

Should you forget a Metviron GP 2 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metviron GP 2 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Metviron GP 2 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Metviron GP 2 Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Metviron GP 2 Tablets and seek immediate medical attention.
Metviron GP 2 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Metviron GP 2 Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Metviron GP 2 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Metviron GP 2 Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metviron GP 2 Tablet and alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Metviron GP 2 Tablet
59
MRP 69
14% off